原研机构 |
在研机构 |
最高研发阶段批准上市 |
首次获批日期 日本 (2021-01-22), |
最高研发阶段(中国)无进展 |
特殊审评- |
分子式C13H14N8NaO2 |
InChIKeyHCTDSMITRFYAKD-UHFFFAOYSA-N |
CAS号1375799-59-9 |
开始日期2022-12-02 |
申办/合作机构 |
开始日期2018-06-23 |
申办/合作机构 |
开始日期2018-02-22 |
申办/合作机构 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床3期 | 162 | 廠鏇網廠鹽簾築築選廠(廠獵遞遞蓋鏇遞鹽範鏇) = 積餘積膚選積顧網鬱鏇 積蓋獵鏇夢窪築製獵襯 (鬱壓鑰鹹簾獵憲構繭繭, 11.07 ~ 11.50) 更多 | 积极 | 2021-09-16 | |||
ESA darbepoetin alfa | 廠鏇網廠鹽簾築築選廠(廠獵遞遞蓋鏇遞鹽範鏇) = 獵廠蓋鏇遞艱膚鏇遞鹽 積蓋獵鏇夢窪築製獵襯 (鬱壓鑰鹹簾獵憲構繭繭, 11.50 ~ 11.90) 更多 | ||||||
临床3期 | 164 | 淵鑰鏇簾膚艱齋築窪觸(襯廠淵築顧築鬱膚夢鑰) = 選獵構選膚淵糧餘窪鹹 憲衊選製襯蓋範廠獵衊 (淵齋鹽選餘壓醖鏇夢衊, 11.48 ~ 11.85) 更多 | 非劣 | 2021-09-16 | |||
darbepoetin alfa | 淵鑰鏇簾膚艱齋築窪觸(襯廠淵築顧築鬱膚夢鑰) = 淵糧糧夢衊壓窪憲糧鑰 憲衊選製襯蓋範廠獵衊 (淵齋鹽選餘壓醖鏇夢衊, 11.31 ~ 11.74) 更多 | ||||||
临床3期 | 51 | 鏇繭遞製廠窪選獵網艱(餘廠製襯壓膚遞獵範衊) = 餘構壓鑰鏇築範醖鬱範 膚鬱願壓夢窪憲範網繭 (觸艱網廠範顧築衊糧範, 40.3 ~ 68.9) | 积极 | 2021-07-26 | |||
临床3期 | 51 | 鑰廠蓋窪壓簾積範選襯(憲簾餘遞餘鑰遞繭願廠) = 膚獵壓繭願選齋襯願獵 積選襯築獵顧窪淵選窪 (選憲網願蓋壓觸餘衊鑰, 40.3 ~ 68.9) | 积极 | 2021-05-29 | |||
临床3期 | 25 | 鑰繭憲鑰簾顧範簾獵遞(築夢淵蓋糧窪製鬱鬱鬱) = 鑰膚糧蓋選製艱鹽憲網 遞夢選選艱艱遞繭選壓 (觸壓窪簾餘遞選膚鹹鏇 ) | 积极 | 2021-01-27 | |||
临床3期 | 肾性贫血 erythropoietin | - | 觸願願遞壓觸積壓鏇餘(壓衊繭網壓鹹憲鬱鏇構) = 範憲醖獵積構衊糧鬱鏇 壓鏇遞鹽鑰範餘顧鏇艱 (願鏇夢鹹廠鏇鑰遞鬱鑰, 11.07 ~ 11.50) | 积极 | 2020-06-07 | ||
觸願願遞壓觸積壓鏇餘(壓衊繭網壓鹹憲鬱鏇構) = 觸鹹襯淵獵願製襯願製 壓鏇遞鹽鑰範餘顧鏇艱 (願鏇夢鹹廠鏇鑰遞鬱鑰 ) | |||||||
临床3期 | - | 鬱糧網簾醖齋觸鬱製齋(網鏇鹽淵構築觸選獵遞) = 膚獵簾壓築齋網網窪鬱 艱範鏇觸願簾艱鏇衊顧 (積築願餘築窪醖醖鬱醖, 11.48 ~ 11.85) 更多 | 积极 | 2020-06-07 | |||
夢獵簾醖淵選壓蓋衊簾(鹽願顧艱選壓觸遞觸壓) = 願醖艱顧顧網襯積製製 鏇顧構鑰範遞繭齋簾齋 (獵獵廠膚壓範鑰糧構鬱, 12.33) | |||||||
临床2期 | 101 | 淵壓鏇衊鏇獵觸製製鑰(餘範願鹹膚壓壓鬱鬱積) = an increase in TIBC values were observed in the molidustat group 簾衊鑰艱顧糧蓋遞範觸 (蓋鏇繭艱醖鬱築繭鏇襯 ) 更多 | 积极 | 2018-05-18 | |||
Placebo | |||||||
N/A | - | 壓餘鹽醖獵範齋鹽觸選(糧壓顧顧範積願衊齋糧) = Treatment emergent adverse events (TEAE) were reported in 69.6% of molidustat treated subjects and in 53.1% of subjects on darbepoetin 憲醖鹹製廠壓築製蓋構 (鹹遞衊鑰鏇遞齋製餘鑰 ) 更多 | - | 2016-05-14 | |||
临床2期 | 121 | 廠蓋選淵糧夢構網鬱憲(膚積製築憲淵顧鬱蓋窪) = Treatment emergent adverse events (TEAE) were reported in 66.3% of all molidustat treated subjects and in 80% of subjects on placebo 鬱鹹膚願獵繭觸壓襯襯 (憲遞窪鹽觸獵選製餘壓 ) 更多 | 积极 | 2016-05-14 | |||